Clinical trial Recruiting at 1 site Observational Ages 18 and up

Impact of diaphragm weakness in ICU patients

Official title: Incidence and Impact of ICU-acquired Diaphragm Weakness

Run by Assistance Publique - Hôpitaux de Paris · NCT06420999 · Data updated 2026-11-12

This study looks at how weak diaphragm muscles affect recovery in ICU patients after they leave the hospital to see if it impacts their breathing and overall health in the following months.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment194 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedJuly 29, 2024
Main results expectedJanuary 29, 2028
Study endsJanuary 29, 2028
Registry record updatedMay 28, 2025
Trial IDNCT06420999 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 years and older who have received respiratory support for at least 48 hours and are being weaned from that support.

Probably not a fit

Patients with known pre-existing diaphragmatic dysfunction or those who are non-communicative may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the incidence and prognostic impact of diaphragm dysfunction in patients discharged from the ICU. It involves assessing diaphragmatic function using ultrasound within 24 hours after weaning from ventilatory support and on the day of ICU discharge. The study aims to correlate diaphragmatic activity with patient outcomes, specifically looking at the relationship between diaphragmatic dysfunction and prognosis within 90 days post-discharge. Dyspnea will also be measured to provide a comprehensive evaluation of respiratory muscle function.

Why it matters

Potential benefit: If successful, this study could lead to improved monitoring and management strategies for ICU patients, potentially reducing readmission rates and improving long-term outcomes.

How similar studies have gone: While the specific focus on ICU-acquired diaphragm weakness is novel, related studies have shown that assessing respiratory muscle function can provide valuable prognostic information.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years
2. Invasive or non-invasive respiratory support (ventilation, high-flow oxygen therapy, whatever the reason) for at least 48 hours.
3. Weaning from respiratory support (invasive or not) within the last 24 hours.
4. Patient (or trusted person/relative) informed and not opposed to the study.

Exclusion Criteria:

1. Known pre-existing diaphragmatic dysfunction (phrenic lesion, neuromuscular disease, etc.)
2. Patients with tracheostomy
3. Non-communicating patients
4. Patients deprived of liberty by court or administrative order, or under legal protection (guardianship, curators).

Where it's running

  • Médecine intensive Réanimation
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.